TL011 in Severe, Active Rheumatoid Arthritis Patients

Study Title

TL011 in Severe, Active Rheumatoid Arthritis Patients

Teva Identifier

RA-TL011-101 | 2009-015702-18

ClinicalTrials.gov Identifier

NCT01123070

Study Status

Completed

Trial Condition(s)

Rheumatoid Arthritis

Interventions

Biological: TL011, anti CD20, for the treatment of rheumatoid arthritis | Biological: MabThera infusions

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
muscle icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 80 Years

Trial Duration

02/01/2010 - 05/01/2012

Phase

Phase 1/2

Study Type

Interventional